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Abstract
Background: Scabies is a parasitic skin infestation caused by the burrowing mite Sarcoptes scabiei. It is common worldwide
and spreads rapidly under crowded conditions, such as those found in socially disadvantaged communities of Indigenous
populations and in developing countries. Pruritic scabies lesions facilitate opportunistic bacterial infections, particularly
Group A streptococci. Streptococcal infections cause significant sequelae and the increased community streptococcal
burden has led to extreme levels of acute rheumatic fever and rheumatic heart disease in Australia’s Indigenous
communities. In addition, emerging resistance to currently available therapeutics emphasizes the need to identify potential
targets for novel chemotherapeutic and/or immunological intervention. Scabies research has been severely limited by the
availability of parasites, and scabies remains a truly neglected infectious disease. We report development of a tractable
model for scabies in the pig, Sus domestica.
Methodology/Principal Findings: Over five years and involving ten independent cohorts, we have developed a protocol for
continuous passage of Sarcoptes scabiei var. suis. To increase intensity and duration of infestation without generating animal
welfare issues we have optimised an immunosuppression regimen utilising daily oral treatment with 0.2mg/kg dexamethasone.
Only mild, controlled side effects are observed, and mange infection can be maintained indefinitely providing large mite numbers
(.6000 mites/g skin) for molecular-based research on scabies. In pilot experiments we explore whether any adaptation of the mite
population is reflected in genetic changes. Phylogenetic analysis was performed comparing sets of genetic data obtained from pig
mites collected from naturally infected pigs with data from pig mites collected from the most recent cohort.
Conclusions/Significance: A reliable pig/scabies animal model will facilitate in vivo studies on host immune responses to
scabies including the relations to the associated bacterial pathogenesis and more detailed studies of molecular evolution
and host adaption. It is a most needed tool for the further investigation of this important and widespread parasitic disease.
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Introduction
Scabies, or sarcoptic mange, is an infectious skin disease caused
by the mite Sarcoptes scabiei. Human scabies is a widespread disease
in developing regions of the world, and remains a significant
problem amongst indigenous populations in developed countries
[1]. Secondary bacterial infections of scabies lesions, most notably
with Group A Streptococcus or Staphylococcus aureus [2], have been
linked to serious complications, such as renal damage and
rheumatic heart disease [3]. Although scabies is unusual in urban
Australia, it is currently endemic in remote northern and central
Australian Aboriginal communities and remains a major public
health problem in these socially disadvantaged communities [4,5].
Over 70% of two year old children in Australia’s remote
Aboriginal communities have been at least once infected with
scabies, most of them acquiring the first infection as infants.
Importantly, these numbers are reflected in the rates of observed
streptococcal skin infections in over 80% of these children [6].
Parasitic mites of the genus Sarcoptes infest up to 40 different
mammalian hosts across 17 families [7]. Commonly described hosts
include dogs, pigs, foxes and wombats. Sarcoptic mange causes
significantlossestoprimaryindustries,especiallyinpigherds,whereit
leads to decreased growth rates and subsequent reduced feed
conversion efficiency [8]. Although effective control has been
achieved in many regions by using macrocyclic lactones such as
ivermectin, administered to sows 4 weeks before farrowing, sarcoptic
mange remains common in piggeries, with reported prevalence from
20–86% [9]. Despite the economic and health significance of S. scabiei
infestation in both human and animal populations, the pathogenesis
and immune responses to this disease is not well understood [10].
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mites cannot be maintained or propagated away from their animal
host, and it is difficult to collect mites in large quantities, as a
typical infestation of human scabies involves fewer than twenty
mites. Access to hyper-infested hosts has enabled the construction
of cDNA libraries from human [11,12] and fox [13] mite
populations. Sequencing these libraries has resulted in the
identification of genes which reveal some unexpected features of
scabies biology and immunopathology [reviewed in 14]. We have
recently shown that scabies mite gut proteases play major roles in
maintaining the mite infestation within the epidermis, either as
digestive enzymes [15], or by providing host complement evasion
mechanisms [16]. Another research focus has been the character-
isation of the molecular basis of emerging acaricide resistance
[17,18].
Despite these recent advances, access to hyper-infested hosts
remains opportunistic and sporadic. Moreover, there has been
an almost complete failure in efforts to maintain viable mites in
the laboratory for longer than 24–48 hours, and no established
methods are available to propagate mites in vitro.T oo v e r c o m e
these barriers, the availability of a tractable animal model for
scabies would be of enormous benefit. Despite being morpho-
logically very similar [19], S. scabiei variants appear to be
predominantly host specific, and investigations whether they
are genetically distinct are ongoing [20,21]. The majority of
cross-infectivity studies have been unsuccessful, with infesta-
tions transient and self limiting [22]. Over several years we
have tried unsuccessfully to propogate mites from crusted
scabies patients, pigs and dogs on immunosuppressed mice.
There is currently only one other animal model for scabies
worldwide, that of canine scabies mites maintained on rabbit
hosts at a U.S laboratory [22]. This trans-species adaptation
was successful only after many attempts, and has not been able
to be repeated (personal communication, L. Arlian Ohio).
While this host-mite system has been extremely valuable for
immunological studies, it has been maintained under strong
drug selection pressure for over two decades [18], and
consequently its utility as a source of live, viable mites is
limited due to logistical difficulties of access for international
research and regulatory restrictions.
When infested with mange, pigs show similar epidermal,
morphological, and immunological changes to humans [23]. Of
significant importance is the fact that pigs have been described to
develop a manifestation of scabies closely resembling human
crusted scabies [24], a poorly understood manifestation. A further
potential advantage of this host-parasite system is the fact that the
complement system in pigs is comparable to humans [25], and
pigs are susceptible to Streptococci, including Group A strepto-
cocci (GAS) [26]. Experimental models of porcine mange have
been used previously to study clinical manifestations [27], effects
on production and transmission dynamics, as well as limited
studies of immunology and histopathology [28]. The majority
have been short-term, naturally resolving infections. Our objective
was to achieve a consistent, reliable quantity of S. scabiei. Herein
we report progress in developing a sustainable experimental model
of chronic porcine mange, which now consistently provides large
numbers of mites, facilitating the less restrictive conduct of
research on human and animal scabies.
Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the Australian code of practice for the care
and use of animals for scientific purposes and the NHMRC’s
Animal Code of Practice, and all animal work conducted with
ethical approval from both DEEDI and QIMR Animal Ethics
Committees (DEEDI-AEC SA2009/07/294, QIMR A0306-
621M).
Mite collections from abattoir samples
Samples were initially sought from pigs for the purpose of
obtaining sufficient mites to attempt transmission of infection to
mice. Six ears from slaughtered pigs with mangy appearance were
supplied to the laboratory in a weekly basis by a Southeast
Queensland abattoir from June 2004 to November 2007. Skin
pieces were dissected from the inner ear and incubated in glass
petri dishes at 27uC, which encourages mites to crawl out towards
the heat source. Dishes were examined and mites picked under a
dissecting microscope using microscopic needles.
Pig Housing
Pigs were housed at the DEEDI Animal Research Institute,
Yeerongpilly, QLD, and at the Centre for Advanced Animal
Studies, Gatton, QLD. It was ensured that the care and the
experimental practices conformed to the Australian animal ethics
guidelines. Pigs with suspected natural mange infections (Table 1,
groups 1–4) were sourced by approaching commercial piggeries,
saleyards and private owners. At a later stage of the study (groups
5–10) naı ¨ve piglets of the ‘‘large white’’ breed - a common meat
producing breed in Australia [29] - were obtained from the
University of Queensland piggery, Gatton, QLD and experimen-
tally infected with mites. To passage the infection, new piglets were
placed into pens adjacent to infected pigs from the previous group.
A heater placed on the fence line encouraged pigs to congregate
and thus enhanced the potential for mite transfer. From groups 6
onwards, mite transmission was additionally ‘boosted’ by the direct
transplant of mite infested skin crusts obtained directly from the
previous group. Briefly, crusts were harvested from infected pigs
and dissected into small pieces (approx 0.5cm
2). Several crusts
were inserted into both ear canals of naı ¨ve piglets. Pigs were
Author Summary
Scabies, a neglected parasitic disease caused by the
microscopic mite Sarcoptes scabiei, is a major driving force
behind bacterial skin infections in tropical settings.
Aboriginal and Torres Strait Islander peoples are nearly
twenty times more likely to die from acute rheumatic fever
and rheumatic heart disease than individuals from the
wider Australian community. These conditions are caused
by bacterial pathogens such as Group A streptococci,
which have been linked to underlying scabies infestations.
Community based initiatives to reduce scabies and
associated disease have expanded, but have been
threatened in recent years by emerging drug resistance.
Critical biological questions surrounding scabies remain
unanswered due to a lack of biomedical research. This has
been due in part to a lack of either a suitable animal model
or an in vitro culture system for scabies mites. The pig/mite
model reported here will be a much needed resource for
parasite material and will facilitate in vivo studies on host
immune responses to scabies, including relations to
associated bacterial pathogenesis, and more detailed
studies of molecular evolution and host adaptation. It
represents the missing tool to extrapolate emerging
molecular data into an in vivo setting and may well allow
the development of clinical interventions.
A Porcine Model of Scabies
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agitation, thereby allowing successful infestation.
Sampling of mites
Skin samples were collected by gently scraping and lifting off
encrusted areas from the inner ear area of the pig with a
sharpened teaspoon and subsequently examined for mites.
DNA preparation, sequencing and data analysis
S. scabiei var. suis DNA from 10 mites collected from one pig
in group 4 in 2006 and from another pig in a later group 10
in 2010 was prepared as described previously [30]. The SMIPP-S-
B2 gene was amplified in a proofreading PCR and products were
purified and sequenced in both directions, with chromatograms
manually inspected for quality. These sequences were then aligned
with SMIPP-S-B2 (AY333073), with the related SMIPP-S-B1
(AY333076), and SMIPP-S-B3 from S. scabiei var. hominis cDNA
used as outgroups (data not shown). Sequence alignments and
subsequent phylogenetic analysis was performed using MEGA4
[31].
Results and Discussion
Mite supply from abattoir collections is sporadic
The quantity of mites obtained from abattoir samples was
variable, exceeding 3,000 mites per ear on some occasions,
whereas at other times no mites were observed for several months
(Figure 1). Although seasonal trends for mange occurrence have
been reported [32], this trend is likely dependent on other
determinants including housing conditions, with pigs in confine-
ment showing less seasonal differences in mite burden [33]. While
there is no obvious seasonal trend apparent from our data
(Figure 1), without having prior knowledge of the source
environment from the samples obtained, we could not investigate
for any association. The results however accord with the known
prevalence of sarcoptic mange in the pig industry, despite the
availability of effective control measures. The sporadic supply of
mites obtained from this approach meant that it was unsuitable as
a sustainable source for laboratory experiments. Clearly, an
alternative approach was needed.
Dexamethasone treatment increases mite burden in pigs
Despite having clinical features of mange, such as scratching
behaviour, hair loss, reddened and flaky skin, the untreated pigs in
groups 1 and 2 either had no or very few mites and symptoms
resolved within 6 weeks of acquisition (Table 1). These obser-
vations are typical for acute-hypersensitive mange in pigs, which is
generally described as a short term infestation with low mite
numbers [27], a clinical picture akin to ordinary human scabies.
To obtain sufficient mites for our studies, pigs with chronic mange
were needed. Chronic mange closely resembles human crusted
scabies, with the formation of hyperkeratotic plaques and
proliferation of mites. It is more commonly observed in older
sows or when pigs are immunosuppressed, and is generally un-
common in growing pigs [27,33].
To increase mite numbers and maintain a prolonged infestation
by counteracting natural immunity, it was proposed to treat
mange infected pigs with corticosteroids. This concept is supported
Table 1. Development of an animal model for scabies, 2004–2009.
Year
Group #
(number of pigs) Source of pigs
Arrival age
(weeks)
Source of
infection DEX treatment
Mites per
harvest (max)
3
Duration of
infection (weeks)
2004 1 (1) Boonah, QLD 60 Natural None 0 0
2004 2 (5) Oakey, QLD 12 Natural None 19 8
2004 3 (4) Cooyar, QLD 4 Natural 0.01mg/kg, injection, 1/wk 50 10
2006 4 (4) Boney Mountain, QLD 3 Natural 0.01mg/kg, injection,3/wk 150 12
2006 5 (3) Piggery, UQ Gatton 3 Passaged
1 Pre-treated, 0.1mg/kg,
injection, 3/wk
300 12
2007 6 (4) Piggery, UQG 3 Passaged+Boosted
2 Pre-treated, 0.1mg/kg,
oral, 3/wk-daily
500 40*
2007 7 (3) Piggery, UQG 3 Passaged+Boosted Pre-treated, 0.1mg/kg, oral, daily .1000 52*
2008 8 (3) Piggery, UQG 3 Passaged+Boosted Pre-treated, 0.25–0.3mg/kg,
oral, daily
.10,000 20*
2009 9 (2) Piggery, UQG 3 Boosted Pre-treated, 0.2mg/kg, oral, daily 100,000 44*
2009 10 (3) Piggery, UQG 3 Passaged+Boosted Pre-treated, 0.2mg/kg, oral, daily 100,000 14*
1Passaged: infection transmitted by housing mange infected pig with naı ¨ve pig.
2Boosted: infection transmitted by transplant of mite infested skin crusts.
3Average harvest involved scraping 4cm
2 ear section.
*Pigs still infected at time of euthanasia.
doi:10.1371/journal.pntd.0000756.t001
Figure 1. Mites collected from south-east Queensland abattoir,
2004–2007. Mites were obtained weekly from six pig ears and total
numbers of mites were counted. The graph shows the trend of mite
numbers for each year and season (June–August=Australian winter
months).
doi:10.1371/journal.pntd.0000756.g001
A Porcine Model of Scabies
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development of crusted scabies in humans [34]. Dexamethasone is
a synthetic glucocorticoid commonly used in animal models to
promote infection and exacerbate infectious responses. It has
pleiotropic effects on immune responses, depressing lymphocyte
production, antibody production and inflammatory responses.
Due to its previous use in other immunosuppression models,
including pigs [35,36], it was selected for study.
Because dexamethasone had not been tested previously in
scabies infected pigs, and to give appropriate consideration to
animal welfare issues, a gradual, conservative treatment program
was initiated.
As naturally infected pigs self cured over time (Table 1, Groups
1 and 2) pigs with existing, naturally acquired mange were treated
(Table 1, Group 3) with weekly injections of 0.01mg/kg of
dexamethasone (Dexafort, Provet, Brisbane). However this did not
increase mite numbers or prolong infection. Mite numbers
improved markedly when dexamethasone was given tri-weekly
but the infestation was not sustained for longer than 12 weeks and
only a single viable mite harvest was possible from each pig
(Table 1, group 4). Because of the possibility that the immune
system was overcoming infection prior to steroid treatment,
dexamethasone treatment was commenced in naı ¨ve piglets prior to
infection. In light of marginal effects observed at lower dosage, the
dexamethasone dosage and frequency was increased to 0.1mg/kg
daily. For these groups (5 and 6) a successful experimental transfer
was observed, with up to 500 mites obtained in a single ear
scraping. Because of concerns regarding aversion behaviours to
daily injections, the delivery method of dexamethasone delivery
was changed from injection (groups 3–5) to oral (Dexamethasone
tablets, 1 or 4mg, Provet, Brisbane), with pigs readily accepting
tablets offered in marshmallows. A further alteration (applied to
groups 6–10) was to boost the passage of mites by directly placing
mite infested skin crusts deep into the ear of piglets. Combined,
these protocol modifications greatly enhanced rate of infection,
with new piglets developing crusted lesions within four weeks. Mite
numbers continuously increased, and one pig maintained infection
for over six months (Table 1, Group 7).
Since 0.1mg/kg appeared to be inadequate to achieve sufficient
immunosuppression, moderate increments in dosage were com-
menced, whereby a sentinal pig was exposed to the higher dose for
six weeks prior to the rest of the group, allowing for observation of
detrimental effects. At 0.3mg/kg pigs started to develop much
larger crusted lesions which also spread to regions beyond the ears
(Figure 2B). At this point, an excess of 10,000 mites were obtained
per harvest, and crusting would re-develop after removal, enabling
multiple harvests (Table 1, Group 8). Given that our objective of
developing sustainable mite supply was achieved, further dose
increases were not undertaken.
At the maximal dose of 0.3mg/kg dexamethasone mite
infestation dramatically increased, but noticeable side effects were
observed. The most obvious of these was a tendency of growth
retardation and a change of body shape. Retardation in weight
gain in dexamethasone treated pigs has been reported [36].
Decreased growth can be attributed to the interference of the
corticosteroid on the hypothalamic-pituitary axis, thus depressing
production of growth hormone. Stunting was not associated with
decreased nutrition uptake, and all pigs had healthy appetites. At
higher doses some pigs also developed hirsutism. Several pigs
developed laxity in hind foot tendons, and in one pig evidence of
excess adiposity and bone demineralisation was observed on post
mortem. Frequent vomiting was observed in one pig. While
dexamethasone is known to increase the risk of gastric ulcers, no
evidence of ulcers or gastrointestinal irritation were observed post-
mortem. Corticosteroids have been used to induce stress responses,
and this was observed in several pigs having decreased ability to
cope with bullying and natural dominance behaviours. This effect
was controlled by housing pigs in pairs or singly, thereby
minimising the requirement to compete for social positioning.
Most these side effects parallel that of iatrogenic Cushing’s
syndrome seen in humans, with glucocorticoid excess resulting in
symptoms such as centralised adiposity, bone osteoporosis,
hirsutism, depression and anxiety. It should be emphasised that
the side effects observed in this study were mild, and aside from the
physical effects, pigs appeared normal in spite of their mange
infestation. Pigs were closely monitored by skilled veterinary staff
for side-effects including increased susceptibility to disease, but
other than mange, no additional infections were observed. Good
husbandry and infection control measures were paramount to this
process.
Since the optimal treatment regimen has now been established,
the dosage of dexamethasone can be adjusted accordingly to
maintain required mite burden, while minimising side effects.
Continued tailoring of dexamethasone is also important since it
became evident through the trial that pigs showed great variation
in inherent immunologic responses to both steroid treatment and
scabies. For example, one pig on low dose dexamethasone still
developed chronic mange and the side effects described above.
Similarly, other pigs had relatively low mite burdens despite
receiving higher doses of dexamethasone. Variation in pig mange
responses are common [27], with small number of pigs in the
population often harbouring the majority of the mite burden [8].
Figure 2. Chronic mange in immunosuppressed pigs. (A) Typical encrustment at peak of infection on pig ear (B) and spread of encrusted
lesions to hocks as a result of increased dexamethasone dosage in group 8. In excess of 6000 mites per gram of skin are obtained. (C) A close up on
piece of crust obtained from a typical harvest viewed through dissecting microscope showing large numbers of females (f), nymphs(n), and eggs (e).
doi:10.1371/journal.pntd.0000756.g002
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stable and transmissible mite population established from an
originally natural infection over five passages. We observed a
striking increase in mite numbers per harvest especially for the last
three groups.
Comparative phylogenetic analysis of mites collected
from naturally infected pigs versus pig mites collected a
recent cohort of the pig/mite model
We propose that the increased mite numbers are at least in part
a direct consequence of the immunosuppression regimen and
reflect the immune status of the pigs. It is however also possible
that the selection towards adapted subpopulations of mites has
occurred via passage through five generations of pigs. Any
adaptation of the mite population should be reflected in genetic
changes. Such changes over time can only be observed in a mite
population within a closed cohort, where there had been no
introduction of mites with potentially new genotypes. As a
indispensable prerequisite for such a study the presented pig/mite
model provides a continuous source of mites and may offer a
controlled setting to monitor genetic changes over time in closed
mite populations. To test the feasability of the model for a large
experimental setup at a later stage we aimed here to compare
limited sets of genetic data obtained from pig mites collected from
a naturally infected pig in group 4 (2006) with data from pig mites
collected from one pig in group 10 (2009). Thus, we were
investigating genetic changes in a closed mite population
maintained isolated for over 3 years.
We focussed on the SMIPP-S-B2 gene, belonging to a multigene
family of at least 32 closely related gut proteases homologous to the
group 3 major allergens of astigmatid house dust mites [37] [38].
Due to mutations in the catalytic triad and considerable structural
rearrangements, these have no proteolytic function, but have
instead evolved into potent inhibitors of each of the three pathways
of the host complement system [16]. The genes in the SMIPP-S
family show considerable sequence diversity, and are hypothesised
to mediate a novel host immune-evasion strategy. Synonymous
versus non-synonymous changes within the coding region of the
mature SMIPP-S protein indicate that SMIPP-Ss most likely have
functions that would be affected by non-synonymous changes and
therefore be subjected to selection pressure [37].
The pig mite derived SMIPP-S-B2 sequences form a distinct
cluster from the corresponding human mite sequence. We also
observed a considerable degree of intra-species heterogeneity. In
the 2006 mite population, three distinct B2 isoforms (B2-1 to 3)
were observed, with polymorphisms at 7 amino acid sites
(Figure 3A) with isoform B2-3 observed most frequently. Analysis
of the 2009 mite population revealed the emergence of five new
isoforms (B2-4 to 8), with isoforms B2-1 and 2 not seen in the
2009 mites. Neighbour-joining analysis suggests these new
isoforms are derived from B2-3 (Figure 3B). Some of the
bootstrap values were low, which is most likely attributable to
the proposed recent evolutionary divergence, also indicated by
the short branch lengths at the respective nodes. Indeed, the
primary source of sequence variation involved polymorphisms at
amino acid residue 184. Whereas human mite sequences contain
an alanine at this site, pig mites in 2006 contained threonine or
aspartic acid, and 2009 pig mites had alanine, threonine, aspartic
acid or glutamate. Sequence alignments of the complete SMIPP-
S family show that this region is highly polymorphic [38].
Moreover, the predicted surface location of this residue suggests
this rapidly evolving divergence may be of functional relevance. It
is suggested the SMIPPs provide a complex network of
immunologically cross-reactive sequences in response to host
antibodies, and thus represent specific genetic adaptations to the
intimate host-parasite relationship [37].
While heterogeneity within the SMIPP family most likely
happens in vivo in human and pig populations, it is difficult to
undertake such studies in human settings. In previous genetic
analysis on mites from human crusted scabies, patients had
been infected over many years and had undergone multiple
treatments over several episodes. In microsatellite data reported
by Walton et al. [20,39] a large degree of genetic diversity in the
mite population within individual hosts was possibly the result of
both recrudescence and re-infection from multiple community
sources. In contrast our animal model provides a controlled
setting to monitor genetic changes over time in closed mite
populations.
Although this SMIPP-S analysis was limited in its scope, it
nevertheless highlights the potential of this model for investigations
of the molecular evolution of scabies mite genes. Representative
isolates collected over the continuing passage of mites through
successive generations may provide fascinating insights into
genetic diversity, evolution and host-adaption of scabies mites,
particularly within the novel SMIPP family.
Figure 3. Genetic changes within a subset of the SMIPP-S
multigene family in a closed mite population. A: Frequency
histogram of the SMIPP-S-B2 sequence isoforms identified in pig mites
in 2006 (grey) and 2009 (black). B: Neighbour-joining bootstrap tree
(500 replicates) showing the type-B subfamily of the scabies mite
inactivated serine protease paralogues (SMIPP-Ss). A multiple sequence
alignment was performed with ClustalW, using the sequences obtained
from the S. scabiei var. hominis cDNA (SMIPP-S-B1, SMIPP-S-B2 and
SMIPP-S-B3) and the SMIPP-S-B2 pig mite sequences identified in 2006
and 2009 (SMIPP-S B2.1–2.8). New isoforms identified in 2009 are
designated by the diamond symbol. Whole numbers at nodes indicate
the percentage of bootstrap support. The tree is drawn to scale, with
branch lengths corresponding to evolutionary distances. Phylogenetic
analysis was conducted using MEGA4 [31].
doi:10.1371/journal.pntd.0000756.g003
A Porcine Model of Scabies
www.plosntds.org 5 July 2010 | Volume 4 | Issue 7 | e756In conclusion, over a prolonged timeframe of five years,
involving ten independent cohorts (32 animals in total), we have
successfully developed a sustainable experimental infestation of
scabies mite on immunosuppressed pigs. Encrustment on the ears
occurs after 6–12 weeks and can be maintained for at least 12
months, depending on drug dosage and individual pig response.
This animal model now consistently provides large mite numbers
(.6000 mites/g skin) for molecular-based research on scabies.
Projects that have benefitted from this to date include detailed
studies of gene expression in scabies mites [40], and the
development of new techniques to measure drug sensitivity
(submitted), pilot studies in preparation to sequence the scabies
mite genome, and histological localisation of various molecules
involved in evasion of host defences [15,16,41].
Most importantly, further research may utilise the full features
of this animal model which facilitates in vivo studies, including
investigation of pig immune responses to scabies and dexameth-
asone pathways of immunosuppression, in addition to more
detailed studies of molecular evolution and host adaption.
Furthermore, our pig model is now at a stage to be optimised as
pig/scabies/GAS model. Such research should result in innovative
tools for the prevention, monitoring and further investigation of
this important and widespread parasitic disease.
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